FDA Authorizes Emergency Use of Pfizer's Pediatric COVID-19 Vaccine for Children Ages 5 to 11

Experts are weighing the benefits and risks of vaccinating all children in this age group, considering the potential impact of COVID-19 on kids and the effectiveness of the vaccine. The Center for Disease Control and Prevention (CDC) must sign off before widespread vaccinations can begin. Doctors who have cared for hospitalized youngsters are urging parents to consider the vaccine, citing its safety and potential to protect against serious illness. The FDA's decision to authorize the emergency use of the vaccine was based on data showing that it is nearly 91% effective in preventing symptomatic COVID-19 in children and that the benefits outweigh the potential risks.

Key Takeaways:

• Over 8,300 hospitalizations of children aged 5-11 have been reported, with about a third requiring intensive care, according to government data.
• The FDA has authorized emergency use of Pfizer's pediatric COVID-19 vaccine for children aged 5-11, but the CDC must still recommend its use before widespread vaccinations can begin.
• Pfizer's kid shots contain a third of the vaccine dose used for people 12 and older and are administered in two shots, three weeks apart, using a smaller needle.
• A study found the kid-size vaccine to be nearly 91% effective in preventing symptomatic COVID-19.
• The FDA examined 3,100 children vaccinated and found that the younger children experienced similar or fewer reactions to vaccine administration compared to teens or young adults.
• The FDA's decision was made after considering the benefits and risks of vaccinating all children in the age group, including the potential for rare side effects such as heart inflammation.
• Youngsters hospitalized with COVID-19 are more likely to have high-risk conditions such as obesity or diabetes, but otherwise healthy children can also get seriously ill.

Statistics:

• 8,300 hospitalizations of children aged 5-11 have been reported (government data)
• 146 deaths have been reported in children aged 5-11 (FDA data)
• 2,268 children were involved in a study of the vaccine's effectiveness
• 16 diagnoses of symptomatic COVID-19 occurred in children given dummy shots, compared to just 3 who got the real vaccination
• 3,100 children were examined for vaccine safety by the FDA

Sources:

• Associated Press
• Centers for Disease Control and Prevention
• Food and Drug Administration
• The Howard Hughes Medical Institute's Department of Science Education